At the dawn of the twenty-first century, the most recent research in molecular biology, advances in genomics, and the resources available due to technological advances in data management enabled the development of a more specific medical approach focusing on the individual genetic make-up and his or her environment.

This P4 Medicine (personalized, predictive, preventive and participatory health care) is expected to redefine health care management. However, the application of such a medical approach also raises certain questions regarding technological, financial, ethical and legal issues, as well as the integration of this approach into health systems already in place. The second International Congress on Personalized Health Care will be held in Montreal from September 23 to 26, 2018 in order to review all these questions and to evaluate the utility of this form of medicine.

The aim of this important event is to bring together more than 800 specialists, researchers, academics, clinicians, managers, economists, representatives of patient associations, ethicists and experts from the pharmaceutical, biotechnology, information and communication technology (ICT) in health and medical technology fields in order to share ideas and pool resources with regards to the development of personalized medicine.